ABAT

Chr 16

4-aminobutyrate aminotransferase

Also known as: GABA-AT, GABAT, NPD009

4-aminobutyrate aminotransferase (ABAT) is responsible for catabolism of gamma-aminobutyric acid (GABA), an important, mostly inhibitory neurotransmitter in the central nervous system, into succinic semialdehyde. The active enzyme is a homodimer of 50-kD subunits complexed to pyridoxal-5-phosphate. The protein sequence is over 95% similar to the pig protein. GABA is estimated to be present in nearly one-third of human synapses. ABAT in liver and brain is controlled by 2 codominant alleles with a frequency in a Caucasian population of 0.56 and 0.44. The ABAT deficiency phenotype includes psychomotor retardation, hypotonia, hyperreflexia, lethargy, refractory seizures, and EEG abnormalities. Multiple alternatively spliced transcript variants encoding the same protein isoform have been found for this gene. [provided by RefSeq, Jul 2008]

GeneReviewsResearchGenerating clinical summary…
LOFmechanismLOEUF 0.57
Clinical SummaryABAT
🧬
Gene-Disease Validity (ClinGen)
genetic developmental and epileptic encephalopathy · ARModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.32) despite low pLI — interpret in context.
📋
ClinVar Variants
48 unique Pathogenic / Likely Pathogenic· 337 VUS of 835 total submissions
📖
GeneReview available — ABAT
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.57LOEUF
pLI 0.006
Z-score 3.29
OE 0.32 (0.200.57)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
0.57Z-score
OE missense 0.91 (0.821.00)
266 obs / 293.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.32 (0.200.57)
00.351.4
Missense OE?0.91 (0.821.00)
00.61.4
Synonymous OE?1.08
01.21.6
LoF obs/exp: 9 / 27.7Missense obs/exp: 266 / 293.6Syn Z: -0.64
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveABAT-related GABA-transaminase deficiencyLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.75top 25%
GOF
0.5759th %ile
LOF
0.3065th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

835 submitted variants in ClinVar

Classification Summary

Pathogenic21
Likely Pathogenic27
VUS337
Likely Benign330
Benign64
Conflicting33
21
Pathogenic
27
Likely Pathogenic
337
VUS
330
Likely Benign
64
Benign
33
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
9
6
6
0
21
Likely Pathogenic
20
4
3
0
27
VUS
6
232
96
3
337
Likely Benign
4
9
169
148
330
Benign
0
2
56
6
64
Conflicting
33
Total39253330157812

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

26 pathogenic / likely-pathogenic (of 85) ClinVar copy-number / structural variants overlap ABAT — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ABAT · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →